FDA Proposes New Guidance To Address Pulse Oximeter Inaccuracies Due to Skin Tone
Federal regulators are calling for larger pulse oximeter clinical studies, to ensure manufacturers examine the accuracy of the devices on all skin tones.
Federal regulators are calling for larger pulse oximeter clinical studies, to ensure manufacturers examine the accuracy of the devices on all skin tones.
Further improvements to medical device quality, surveillance and the medical device recall program are planned by the FDA throughout 2024.
Concerns about the safety and accuracy of pulse oximeters for people with darker skin will be reviewed by health experts at a panel advisory meeting in February 2024
Prior warnings indicated that paclitaxel coated implantable devices may increase risk of death by up to 50%, but agency indicates the information is not supported by current data
Prior warnings and recalls of the limb-lengthening implants have raised concerns about biocompatibility problems, leading the FDA to warn doctors to remove the devices after one year.
Several models of Illumina DNA sequencing devices have cybersecurity flaws that could allow hackers to access patient information, warns FDA
Doctors say they see much higher rates of CoolSculpting side effects, such as abnormal bulges, than indicated on the device's warning label.
A growing rise in cybersecurity hacking attempts have been identified since the beginning of the COVID-19 pandemic, leading to increased attention on preventative measures
More than 700 Sterigenics lawsuits have been filed over claims the company knowingly released toxic chemicals into the air near its facilities in Illinois and Georgia.
Manufacturers often use data from adults to determine the safety and efficiency of pediatric heart devices, researchers found.